Keyword: Olivier Brandicourt
News
09.05.2016
- Sanofi is turning up the heat on its acquisition target, US biopharmaceuticals producer Medivation, but the strategy doesn’t seem to be working. Last week, the French drugmaker...
News
14.01.2016
- French drugmaker Sanofi has simultaneously announced collaborations with two biotechnology firms, together worth up to €1.2 billion. The first link-up, worth $750 million (€690...
News
16.12.2015
- French drugmaker Sanofi and German pharmaceutical company Boehringer Ingelheim have begun exclusive negotiations toward a swap of Sanofi’s subsidiary Merial, a manufacturer of...
Markets & Companies
07.10.2015
- After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...
News
01.09.2015
- French pharmaceutical producer Sanofi has announced plans to cooperate with the life sciences team at Google to improve care and outcomes for people with type 1 and type 2 diabetes...
News
16.07.2015
- French drugmaker Sanofi has announced plans to streamline its corporate structure with effect from January 2016. The company pointed to its heritage formed from a combination of...
News
03.03.2015
- French pharmaceuticals producer group Sanofi has come under fire from French government ministers over a welcome bonus planned for its new CEO. Olivier Brandicourt, who moves to...
News
26.02.2015
- Richard Pott, until 2013 Bayer group managing board with responsibility for Strategy and Human Resources along with the regions Americas, Africa and Middle East, has been approved...
